1. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer. Issue 1 (December 2017) Authors: Hashim, Yassar; Vangveravong, Suwanna; Sankpal, Narendra; Binder, Pratibha; Liu, Jingxia; Goedegebuure, S.; Mach, Robert; Spitzer, Dirk; Hawkins, William Journal: Journal of experimental & clinical cancer research Issue: Volume 36:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Which Trauma Patients Require Lower Enoxaparin Dosing for Venous Thromboembolism Prophylaxis?. Issue 10 (6th November 2020) Authors: Veatch, Jessica; Hashim, Yassar; Dhillon, Navpreet K.; Toscano, Samantha; Mason, Russell; Lin, Ting-Lung; Barmparas, Galinos; Ley, Eric J. Journal: American surgeon Issue: Volume 86:Issue 10(2020) Page Start: 1424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗